Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization

Baluk, 2005, Cellular abnormalities of blood vessels as targets in cancer, Curr. Opin. Genet. Dev., 15, 102, 10.1016/j.gde.2004.12.005 Bergers, 2008, Modes of resistance to anti-angiogenic therapy, Nat. Rev. Cancer, 8, 592, 10.1038/nrc2442 Carmeliet, 1999, Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis, Cell, 98, 147, 10.1016/S0092-8674(00)81010-7 Couvelard, 2008, Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors, Clin. Cancer Res., 14, 6634, 10.1158/1078-0432.CCR-07-5258 Dutta, 2008, Activation of the VEGFR1 chromatin domain: An angiogenic signal-ETS1/HIF-2alpha regulatory axis, J. Biol. Chem., 283, 25404, 10.1074/jbc.M804349200 Epstein, 2001, C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, Cell, 107, 43, 10.1016/S0092-8674(01)00507-4 Fischer, 2007, Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels, Cell, 131, 463, 10.1016/j.cell.2007.08.038 Gerhardt, 2008, Pericytes: gatekeepers in tumour cell metastasis?, J. Mol. Med., 86, 135, 10.1007/s00109-007-0258-2 Gerhardt, 2003, VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia, J. Cell Biol., 161, 1163, 10.1083/jcb.200302047 Grazia Lampugnani, 2003, Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148, J. Cell Biol., 161, 793, 10.1083/jcb.200209019 Greenberg, 2008, A role for VEGF as a negative regulator of pericyte function and vessel maturation, Nature, 456, 809, 10.1038/nature07424 Hamzah, 2008, Vascular normalization in Rgs5-deficient tumours promotes immune destruction, Nature, 453, 410, 10.1038/nature06868 Hellstrom, 2007, Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis, Nature, 445, 776, 10.1038/nature05571 Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819 Jones, 2008, Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability, Nat. Med., 14, 448, 10.1038/nm1742 Kaelin, 2008, Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway, Mol. Cell, 30, 393, 10.1016/j.molcel.2008.04.009 Kappas, 2008, The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching, J. Cell Biol., 181, 847, 10.1083/jcb.200709114 Kashiwagi, 2008, Perivascular nitric oxide gradients normalize tumor vasculature, Nat. Med., 14, 255, 10.1038/nm1730 Kearney, 2004, The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis, Blood, 103, 4527, 10.1182/blood-2003-07-2315 Kitamura, 2008, Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin, Nat. Cell Biol., 10, 329, 10.1038/ncb1695 Kuhlencordt, 2004, Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells, Am. J. Physiol. Cell Physiol., 286, C1195, 10.1152/ajpcell.00546.2002 Le Bras, 2007, HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites, Oncogene, 26, 7480, 10.1038/sj.onc.1210566 Lee, 2008, The biphasic role of the hypoxia-inducible factor prolyl-4-hydroxylase, PHD2, in modulating tumor-forming potential, Mol. Cancer Res., 6, 829, 10.1158/1541-7786.MCR-07-2113 Lofstedt, 2007, Hypoxia inducible factor-2alpha in cancer, Cell Cycle, 6, 919, 10.4161/cc.6.8.4133 Marxsen, 2004, Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases, Biochem. J., 381, 761, 10.1042/BJ20040620 Milkiewicz, 2004, Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice, J. Physiol., 560, 21, 10.1113/jphysiol.2004.069757 Minamishima, 2008, Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure, Blood, 111, 3236, 10.1182/blood-2007-10-117812 Nangaku, 2007, A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia, Arterioscler. Thromb. Vasc. Biol., 27, 2548, 10.1161/ATVBAHA.107.148551 Peng, 2000, The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling, Proc. Natl. Acad. Sci. USA, 97, 8386, 10.1073/pnas.140087397 Pospisilik, 2007, Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes, Cell, 131, 476, 10.1016/j.cell.2007.08.047 Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187 Stockmann, 2008, Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis, Nature, 456, 814, 10.1038/nature07445 Sullivan, 2007, Hypoxia-driven selection of the metastatic phenotype, Cancer Metastasis Rev., 26, 319, 10.1007/s10555-007-9062-2 Taddei, 2008, Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5, Nat. Cell Biol., 10, 923, 10.1038/ncb1752 Takeda, 2007, Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation, Hypertension, 49, 178, 10.1161/01.HYP.0000251360.40838.0f Takeda, 2007, Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system, Circulation, 116, 774, 10.1161/CIRCULATIONAHA.107.701516 Takeda, 2008, Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins, Blood, 111, 3229, 10.1182/blood-2007-09-114561 Thurston, 2007, The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth, Nat. Rev. Cancer, 7, 327, 10.1038/nrc2130 Winkler, 2004, Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases, Cancer Cell, 6, 553 Wu, 2008, Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene, Mol. Ther., 16, 1227, 10.1038/mt.2008.90 Yamashita, 2008, Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1, J. Biol. Chem., 283, 18926, 10.1074/jbc.M709133200